Pathophysiology of lipid droplet proteins in liver diseases.

Carr RM, Ahima RS. 2016

Insulin resistance in clinical and experimental alcoholic liver disease.                                  Carr RM, Correnti J. 2015

FXR agonists as therapeutic agents for non-alcoholic fatty liver disease.                              Carr RM, Reid AE. 2015

Absence of perilipin 2 prevents hepatic steatosis, glucose intolerance and ceramide accumulation in alcohol-fed mice.

Carr RM, Peralta G, Yin X, Ahima RS. 2014

Temporal effects of ethanol consumption on energy homeostasis, hepatic steatosis, and insulin sensitivity in mice.

Carr RM, Dhir R, Yin X, Agarwal B, Ahima RS.2013

Understanding the pathogenesis of insulin resistance in non-alcoholic and alcoholic liver diseases.

Carr RM. 2013

Reduction of TIP47 improves hepatic steatosis and glucose homeostasis in mice.

Carr RM, Patel RT, Rao V, Dhir R, Graham MJ, Crooke RM, Ahima RS. 2012

Alas! Ileal interposition surgery for diabetes prevention?                                                        Ahima RS, Carr RM. 2010

At the crossroads in the management of gastroesophageal junction carcinomas-where do we go from here?

Carr RM, Lynch JP. 2008

Perilipin staining distinguishes between steatosis and non-alcoholic steatohepatitis in adults and children

Carr RM, Dhir R,Mahadev K,  Comerford M, Chalasani NP, Ahima RS. 2016